Coronary thrombosis due to heparin-induced thrombocytopenia after percutaneous coronary intervention: Easy to miss, uneasy to prevent

This article advises that heparin-induced thrombocytopenia (HIT) should always be considered in cases of unexplained post-PCI coronary thrombosis, and suggests that a pragmatic approach with bivalirudin may be reasonable even without confirmed laboratory diagnosis. The abstract discusses bivalirudin as an alternative anticoagulant in this clinical context but provides no detail on its pharmacological origin or relationship to hirudin or leech-derived substances. There is no mention of leeches, leech therapy, or the leech secretome anywhere in the abstract. Accordingly, this article has no defensible or direct relevance to ASH's domain of hirudotherapy or the leech secretome; any connection would be speculative and unsupported by the source text.